June 13, 2021 1:05 pm
Vaxzevria vaccines (the new name by which Astrazeneca is identified) and Janssen for those over 60, while for those under 60 who have received a first dose of Vaxzevria vaccine, they will receive the second dose with an m-Rna vaccine. In summary, the provision of the Puglia Region on the vaccination campaign, which is updated – as communicated by the Councilor for Health, Pier Luigi Lopalco and by the Director of the Health Department, Vito Montanaro – to the provisions of the Ministry of Health on the updating of the opinion of the CTS .
Provisions to which all vaccination hubs will have to adapt, including those of the company: “For the administration of viral vector vaccines (Vaxzevria and Janssen) – reads a note – the use of viral vector vaccines is made available exclusively to subjects aged above or equal to 60 years of age, while subjects under the age of 60 who have already received a dose of Vaxzevria vaccine will receive the second dose with an m-RNA vaccine 8-10 weeks after the first dose. All remaining subjects under the age of 60 and not yet vaccinated will be given an m-RNA vaccine. “